Verve Therapeutics News

Cathie Wood-Led Ark Invest Sells $1.5M Worth Of Robinhood Shares Amid Muted Bitcoin Market

Ark Invest, led by Cathie Wood, made significant trades on Wednesday involving $Robinhood(HOOD.US)$ and $Zoom Video Communications(ZM.US)$.The Robinhood TradeArk Invest sold 64,706 shares of Robinhood

BenzingaJun 12 23:22 ET

Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock

On Thursday, Cathie Wood-led Ark Invest made significant trades in Amazon.com Inc (NASDAQ:AMZN) and Reddit Inc (NYSE:RDDT), amidst notable developments in both companies.The Amazon.com Trade: Ark Inve

BenzingaJun 6 22:25 ET

Express News | Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersMay 31 16:01 ET

Verve Therapeutics Names Lister as Chief Scientific Officer

Seeking AlphaMay 31 07:08 ET

Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, May 31, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing me

Verve TherapeuticsMay 31 00:00 ET

Verve Therapeutics Announces Leadership Update

Troy Lister, Ph.D., to be promoted to chief scientific officerAndrew Bellinger, M.D., Ph.D., will depart the Company and serve in an advisory capacity BOSTON, May 31, 2024 (GLOBE NEWSWIRE) -- Verve

Verve TherapeuticsMay 31 00:00 ET

Verve Therapeutics to Participate in Upcoming Investor Conferences

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing me

Verve TherapeuticsMay 30 00:00 ET

Verve Therapeutics Slides As Insider Purchases Lose Another US$55k

The recent price decline of 11% in Verve Therapeutics, Inc.'s (NASDAQ:VERV) stock may have disappointed insiders who bought US$475.8k worth of shares at an average price of US$6.26 in the past 12 mont

Simply Wall StMay 22 11:41 ET

Verve Therapeutics Gains as COO Buys Shares

Seeking AlphaMay 16 11:20 ET

Verve Therapeutics CFO Andrew Ashe Executes Purchase of 76,000 Shares of Common Stock; Shares Jump Premarket

06:50 AM EDT, 05/16/2024 (MT Newswires) -- Verve Therapeutics CFO Andrew Ashe Executes Purchase of 76,000 Shares of Common Stock; Shares Jump Premarket Price: 6.65, Change: +0.42, Percent Change: +6.7

MT NewswiresMay 16 06:50 ET

Verve Therapeutics(VERV.US) Officer Buys US$475.76K in Common Stock

$Verve Therapeutics(VERV.US)$ Officer Ashe Andrew D. purchased 76,000 shares of common stock on May 14, 2024 at an average price of $6.26 for a total value of $475.76K.Source: Announcement What is sta

moomoo NewsMay 15 18:09 ET

Buy Rating Affirmed for Verve Therapeutics Amidst Promising Trials and Strong Financials

TipRanksMay 10 08:17 ET

Analysts Are Betting On Verve Therapeutics, Inc. (NASDAQ:VERV) With A Big Upgrade This Week

Yahoo FinanceMay 10 07:06 ET

Express News | HC Wainwright & Co. Reiterates Buy on Verve Therapeutics, Maintains $15 Price Target

BenzingaMay 9 14:55 ET

Verve Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 140.19% HC Wainwright & Co. → $15 Reiterates Buy → Buy 04/03/2024 540.51% Stifel $56 → $40 Main

BenzingaMay 9 14:53 ET

RBC Capital Keeps Their Buy Rating on Verve Therapeutics (VERV)

TipRanksMay 9 06:55 ET

Buy Rating for Verve Therapeutics: Financial Stability and Promising Clinical Trials Underpin Growth Potential

TipRanksMay 9 06:44 ET

Verve Therapeutics' Financial Outlook Threatened by CRISPR Patent Disputes

TipRanksMay 9 02:03 ET

Express News | Verve Therapeutics Inc : Jefferies Cuts Target Price to $28 From $31

ReutersMay 9 01:20 ET

Buy Rating Affirmed for Verve Therapeutics Amid Progress and Promising Pipeline

TipRanksMay 8 13:55 ET